🇺🇸 FDA
Pipeline program

Active Surveillance

H23-02447

Phase 3 other active

Quick answer

Active Surveillance for Muscle-Invasive Bladder Carcinoma is a Phase 3 program (other) at Black Diamond Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Black Diamond Therapeutics
Indication
Muscle-Invasive Bladder Carcinoma
Phase
Phase 3
Modality
other
Status
active

Clinical trials